154 related articles for article (PubMed ID: 11450593)
1. Reversibility of hepatic fibrosis: from the first report of collagenase in the liver to the possibility of gene therapy for recovery.
Okazaki I; Watanabe T; Hozawa S; Niioka M; Arai M; Maruyama K
Keio J Med; 2001 Jun; 50(2):58-65. PubMed ID: 11450593
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of the reversibility of hepatic fibrosis: with special reference to the role of matrix metalloproteinases.
Okazaki I; Watanabe T; Hozawa S; Arai M; Maruyama K
J Gastroenterol Hepatol; 2000 Mar; 15 Suppl():D26-32. PubMed ID: 10759217
[TBL] [Abstract][Full Text] [Related]
3. Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride.
Watanabe T; Niioka M; Hozawa S; Kameyama K; Hayashi T; Arai M; Ishikawa A; Maruyama K; Okazaki I
J Hepatol; 2000 Aug; 33(2):224-35. PubMed ID: 10952240
[TBL] [Abstract][Full Text] [Related]
4. Enhanced interstitial collagenase (matrix metalloproteinase-13) production of Kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis.
Hironaka K; Sakaida I; Matsumura Y; Kaino S; Miyamoto K; Okita K
Biochem Biophys Res Commun; 2000 Jan; 267(1):290-5. PubMed ID: 10623612
[TBL] [Abstract][Full Text] [Related]
5. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis.
Iredale JP; Benyon RC; Arthur MJ; Ferris WF; Alcolado R; Winwood PJ; Clark N; Murphy G
Hepatology; 1996 Jul; 24(1):176-84. PubMed ID: 8707259
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase functions in hepatic injury and fibrosis.
Roderfeld M
Matrix Biol; 2018 Aug; 68-69():452-462. PubMed ID: 29221811
[TBL] [Abstract][Full Text] [Related]
7. [Gene expression of MMPs and TIMPs in the process of hepatic fibrosis].
Okazaki I; Arai M; Wada N; Maruyama K
Nihon Rinsho; 1993 Feb; 51(2):428-34. PubMed ID: 8464157
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.
Iredale JP; Benyon RC; Pickering J; McCullen M; Northrop M; Pawley S; Hovell C; Arthur MJ
J Clin Invest; 1998 Aug; 102(3):538-49. PubMed ID: 9691091
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase gene delivery for liver fibrosis.
Iimuro Y; Brenner DA
Pharm Res; 2008 Feb; 25(2):249-58. PubMed ID: 17577645
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix degradation and the role of hepatic stellate cells.
Benyon RC; Arthur MJ
Semin Liver Dis; 2001 Aug; 21(3):373-84. PubMed ID: 11586466
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver.
Milani S; Herbst H; Schuppan D; Grappone C; Pellegrini G; Pinzani M; Casini A; Calabró A; Ciancio G; Stefanini F
Am J Pathol; 1994 Mar; 144(3):528-37. PubMed ID: 8129038
[TBL] [Abstract][Full Text] [Related]
12. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver.
Benyon RC; Iredale JP; Goddard S; Winwood PJ; Arthur MJ
Gastroenterology; 1996 Mar; 110(3):821-31. PubMed ID: 8608892
[TBL] [Abstract][Full Text] [Related]
13. Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum.
Liu K; Olofsson JI; Wahlberg P; Ny T
Endocrinology; 1999 Nov; 140(11):5330-8. PubMed ID: 10537164
[TBL] [Abstract][Full Text] [Related]
14. Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell.
Sakaida I; Hironaka K; Kimura T; Terai S; Yamasaki T; Okita K
Life Sci; 2004 Mar; 74(18):2251-63. PubMed ID: 14987950
[TBL] [Abstract][Full Text] [Related]
15. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
Hu YB; Li DG; Lu HM
J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking.
Issa R; Zhou X; Constandinou CM; Fallowfield J; Millward-Sadler H; Gaca MD; Sands E; Suliman I; Trim N; Knorr A; Arthur MJ; Benyon RC; Iredale JP
Gastroenterology; 2004 Jun; 126(7):1795-808. PubMed ID: 15188175
[TBL] [Abstract][Full Text] [Related]
17. [Pathomorphology of acute and chronic stages of CCl4-induced liver fibrosis: immunohistochemical and in situ hybridization studies].
Herbst H; Milani S; Heinrichs O; Schuppan D
Z Gastroenterol; 1992 Mar; 30 Suppl 1():21-8. PubMed ID: 1449012
[TBL] [Abstract][Full Text] [Related]
18. Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo.
Williams EJ; Benyon RC; Trim N; Hadwin R; Grove BH; Arthur MJ; Unemori EN; Iredale JP
Gut; 2001 Oct; 49(4):577-83. PubMed ID: 11559657
[TBL] [Abstract][Full Text] [Related]
19. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice.
Roderfeld M; Weiskirchen R; Wagner S; Berres ML; Henkel C; Grötzinger J; Gressner AM; Matern S; Roeb E
FASEB J; 2006 Mar; 20(3):444-54. PubMed ID: 16507762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
